Motley Fool Staff

These Motley Fool Options reviews should help you make a more informed decision about whether the service is right for you.

Since 2004, both The Motley Fool's Inside Value and Hidden Gems services have handily beaten the market. Here's what sets these leading stock newsletters apart.

Shopify is growing at a breakneck speed, but the way its making those sales isn't immediately apparent.

8point3's impressive dividend yield might send up warning flags for wary investors -- here's why it's so high.

Despite its mammoth size, Facebook still has an impressive runway for growth, but there are a few big issues it’ll have to address.

Our analysts share some context for a measurement of power that’s often thrown around when we're talking about renewable energy production.

Getting into investing can be overwhelming. Here are two pieces of advice from the Fool's analysts.

One of the Fool's energy experts makes the case for GE as a diversified, well-hedged investment for both fossil fuels and green energy.

We've updated our Terms and Conditions and are doing away with prorated refunds.

How a yieldco like 8point3 Energy Partners makes money, what it does, and why long-term investors who want to get into the energy space should take a look into it.

The latest innovation in blood thinners could make investors heart-stopping profits.

In this Valentine's Day special edition of Industry Focus, we explore a leading company in heart surgery.

In this Valentine's Day special edition of Industry Focus, we explore cholesterol busters, heart surgery, and the latest in anticoagulants.

While the Dodd-Frank Act of 2010 was intended to solve the too-big-to-fail problem, there’s reason to believe that this isn’t an issue that will ever go away.

Pitting gene-sequencing specialist Illumina against biotech Gilead Sciences to see which company is the better buy for long-term investors.

By limiting banks’ ability to engage in proprietary trading, the Volcker rule is one of the Dodd-Frank Act’s most controversial provisions.

It’s fair to say that the Consumer Financial Protection Bureau is the single most controversial aspect of the Dodd-Frank Act.

The gene sequencing pioneer is undeniably expensive -- and yet still undeniably attractive.

There are few aspects of the Dodd-Frank Act that are more controversial than its capital and liquidity requirements.

How companies and states are making decisions around renewable energy, and why the industry is booming.